Related Experiment Videos
Pharmacogenomic data submissions to the FDA: non-clinical case studies
John K Leighton1, Joseph DeGeorge, David Jacobson-Kram
1Division of Oncology Drug Products, CDER, FDA, 5600 Fishers Lane, Rockville, MD 20850, USA. leightonj@cder.fda.gov
Pharmacogenomics
|June 24, 2004
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A quantitative weight-of-evidence review of preclinical studies examining the potential carcinogenicity of acetaminophen.
Regulatory toxicology and pharmacology : RTP·2026
Comprehensive review of octocrylene toxicology data and human exposure assessment for personal care products.
Critical reviews in toxicology·2026
Comprehensive review of ensulizole toxicology data and human exposure assessment for personal care products.
Critical reviews in toxicology·2025
Comprehensive review of avobenzone (butyl methoxydibenzoylmethane) toxicology data and human exposure assessment for personal care products.
Critical reviews in toxicology·2025
FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-Unresponsive Carcinoma In Situ.
Clinical cancer research : an official journal of the American Association for Cancer Research·2025
FDA Approval Summary: Niraparib plus Abiraterone Acetate Fixed-Dose Combination for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2025
The pharmacogenetic of cyclosporine in Tunisian renal transplantation.
Pharmacogenomics·2026
Psychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs).
Naunyn-Schmiedeberg's archives of pharmacology·2026
Beyond Bayesian integration: how meaning shapes placebo effects.
Trends in neurosciences·2026
Sex-specific cardiometabolic remodeling induced by DPP-4 inhibition under high-fat diet: insights from cardiac proteomics.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
A comparative evaluation of new prebiotic candidates. Part 2: In vitro assays using faecal inoculum from IBD patients.
Food research international (Ottawa, Ont.)·2026